These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28471093)

  • 21. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous coronary intervention vs coronary artery bypass grafting for left main coronary artery disease? A systematic review and meta-analysis of randomized controlled trials.
    Sharma SP; Dahal K; Khatra J; Rosenfeld A; Lee J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28371437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus.
    Harskamp RE; Walker PF; Alexander JH; Xian Y; Liberman HA; de Winter RJ; Vassiliades TA; Peterson ED; Puskas JD; Halkos ME
    Am Heart J; 2014 Oct; 168(4):471-8. PubMed ID: 25262256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Outcomes After Hybrid Coronary Revascularization Versus Coronary Artery Bypass Grafting: Meta-Analysis of Kaplan-Meier-Derived Data.
    Shimamura J; Miyamoto Y; Hibino M; Fukuhara S; Takayama H; Itagaki S; Takagi H; Kuno T
    Am J Cardiol; 2024 Feb; 212():13-22. PubMed ID: 38008347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Barbarawi M; Zayed Y; Hamid K; Kheiri B; Barbarawi O; Sundus S; Rashdan L; Alabdouh A; Chahine A; Bachuwa G; Alkotob ML
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1184-1189. PubMed ID: 30842042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimally Invasive CABG or Hybrid Coronary Revascularization for Multivessel Coronary Diseases: Which Is Best? A Systematic Review and Metaanalysis.
    Guan Z; Zhang Z; Gu K; Wang H; Lin J; Zhou W; Wan F
    Heart Surg Forum; 2019 Dec; 22(6):E493-E502. PubMed ID: 31895036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid total arterial minimally invasive off-pump coronary revascularization and percutaneous coronary intervention strategy for multivessel coronary artery disease: a cohort study with a median 11-year follow-up.
    Rufa M; Ursulescu A; Nagib R; Albert M; Franke UFW
    Cardiovasc Diagn Ther; 2024 Apr; 14(2):272-282. PubMed ID: 38716312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized Clinical Trial of Hybrid vs. Surgical vs. Percutaneous Multivessel Coronary Revascularization: 5‑year Follow-up of HREVS Trial.
    Ganyukov VI; Kochergin NA; Shilov AA; Tarasov RS; Kozyrin KA; Prokudina ES; Barbarash OL; Barbarash LS
    Kardiologiia; 2023 Dec; 63(11):57-63. PubMed ID: 38088113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival in triple-vessel disease: Hybrid coronary revascularization compared to contemporary revascularization methods.
    Basman C; Hemli JM; Kim MC; Seetharam K; Brinster DR; Pirelli L; Kliger CA; Scheinerman SJ; Singh VP; Patel NC
    J Card Surg; 2020 Oct; 35(10):2710-2718. PubMed ID: 32725629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: a meta-analysis.
    Yu L; Zhu K; Du N; Si Y; Liang J; Shen R; Chen B
    J Cardiothorac Surg; 2022 Jun; 17(1):147. PubMed ID: 35672788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
    Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes of Revascularization Strategies for Patients With MVD/LMCA Disease: A Systematic Review and Network Meta-Analysis.
    Fan MK; Su YM; Cai XX; Gu ZS; Geng HH; Pan HY; Zhu JH; Pan M
    Medicine (Baltimore); 2015 Oct; 94(42):e1745. PubMed ID: 26496289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.
    De Luca G; Schaffer A; Verdoia M; Suryapranata H
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is hybrid coronary revascularization really beneficial in the long term?
    Wang C; Li P; Zhang F; Li J; Kong Q
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1158-1166. PubMed ID: 34151954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hybrid coronary revascularization versus conventional coronary artery bypass grafting: Systematic review and meta-analysis.
    Reynolds AC; King N
    Medicine (Baltimore); 2018 Aug; 97(33):e11941. PubMed ID: 30113498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Effectiveness of Hybrid Coronary Revascularization vs Coronary Artery Bypass Grafting.
    Harskamp RE; Vassiliades TA; Mehta RH; de Winter RJ; Lopes RD; Xian Y; Peterson ED; Puskas JD; Halkos ME
    J Am Coll Surg; 2015 Aug; 221(2):326-34.e1. PubMed ID: 25899734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous Hybrid Coronary Revascularization vs Conventional Strategies for Multivessel Coronary Artery Disease: A 10-Year Follow-Up.
    Ding T; Yuan X; Chen K; Shen L; Guan C; Lv F; Xiong H; Xu B; Wu Y; Hu S
    JACC Cardiovasc Interv; 2023 Jan; 16(1):50-60. PubMed ID: 36599587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.
    Al Ali J; Franck C; Filion KB; Eisenberg MJ
    JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.